UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations

Gut, 2006-03, Vol.55 (suppl 1), p.i36-i58

2006

Volltextzugriff (PDF)

Colectomy rate in acute severe ulcerative colitis in the infliximab era

Digestive and liver disease, 2008-10, Vol.40 (10), p.821-826

2008

Volltextzugriff (PDF)

Early versus late surgery for ileo‐caecal Crohn’s disease

Alimentary pharmacology & therapeutics, 2007-11, Vol.26 (10), p.1303-1312

2007

Volltextzugriff (PDF)

Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis

European journal of clinical investigation, 2009-02, Vol.39 (2), p.145-156

2009

Volltextzugriff (PDF)

Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (9), p.908-918

2009

Volltextzugriff (PDF)

Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial

European journal of clinical investigation, 2003-03, Vol.33 (3), p.244-248

2003

Volltextzugriff (PDF)

Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen

Digestive and liver disease, 2009-04, Vol.41 (4), p.269-276

2009

Volltextzugriff (PDF)

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease

Digestive and liver disease, 2009-02, Vol.41 (2), p.166-168

2009

Volltextzugriff (PDF)

Leukocytapheresis as promising therapy for inflammatory bowel disease

Digestive and liver disease, 2007-05, Vol.39 (5), p.435-437

2007

Volltextzugriff (PDF)

Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid

European journal of clinical investigation, 2008-06, Vol.38 (6), p.410-420

2008

Volltextzugriff (PDF)

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

Gut, 2000-09, Vol.47 (3), p.410-414

2000

Volltextzugriff (PDF)

Infliximab in refractory pouchitis complicated by fistulae following ileo‐anal pouch for ulcerative colitis

Alimentary pharmacology & therapeutics, 2003-05, Vol.17 (10), p.1263-1271

2003

Volltextzugriff (PDF)

Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (4), p.517-523

2003

Volltextzugriff (PDF)

Recent advances in the management of Crohn's disease

Digestive and liver disease, 2008-09, Vol.40 (9), p.709-716

2008

Volltextzugriff (PDF)

Seasonal variations in onset of symptoms in Crohn's disease

Digestive and liver disease, 2006-05, Vol.38 (5), p.319-323

2006

Volltextzugriff (PDF)

Early or late guided missile in the treatment of Crohn's disease?

Digestive and liver disease, 2005-12, Vol.37 (12), p.973-979

2005

Volltextzugriff (PDF)

The association of MYO9B gene in Italian patients with inflammatory bowel diseases

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (3), p.241-248

2008

Volltextzugriff (PDF)

The association of MY09B gene in Italian patients with inflammatory bowel diseases

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (3), p.241-248

2008

Volltextzugriff (PDF)

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

Digestive and liver disease, 2005-02, Vol.37 (2), p.92-96

2005

Volltextzugriff (PDF)

Mesalazine vanishing time from rectal mucosa following its topical administration

Journal of Crohn's and colitis, 2010-02, Vol.4 (1), p.102-105

2010

Volltextzugriff (PDF)

Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients

European journal of clinical nutrition, 2003-09, Vol.57 (9), p.1116-1119

2003

Volltextzugriff (PDF)

Short‐chain fatty acid topical treatment in distal ulcerative colitis

Alimentary pharmacology & therapeutics, 1995-06, Vol.9 (3), p.309-313

1995

Volltextzugriff (PDF)

Topical butyrate for acute radiation proctitis: randomised, crossover trial

The Lancet (British edition), 2000-10, Vol.356 (9237), p.1232-1235

2000

Volltextzugriff (PDF)

An unusual complicated polypectomy and inverted colonic diverticula

Colorectal disease, 2010-05, Vol.12 (5), p.491-492

2010

Volltextzugriff (PDF)

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement

Digestive and liver disease, 2005-06, Vol.37 (6), p.407-417

2005

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(140)
Science & Technology
(123)
Life Sciences & Biomedicine
(122)
Male
(82)
Gastroenterology & Hepatology
(80)
Female
(76)
Biological And Medical Sciences
(71)
Medical Sciences
(68)
Adult
(67)
Middle Aged
(60)
Aged
(36)
Gastroenterology. Liver. Pancreas. Abdomen
(33)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(32)
Other Diseases. Semiology
(30)
Adolescent
(26)
Ulcerative Colitis
(22)
Digestive System
(19)
Crohn's Disease
(17)
Pharmacology. Drug Treatments
(17)
Animals
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations

Colectomy rate in acute severe ulcerative colitis in the infliximab era

Early versus late surgery for ileo‐caecal Crohn’s disease

Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis

Clinical trial: ulcerative colitis maintenance treatment with 5‐ASA: a 1‐year, randomized multicentre study comparing MMX® with Asacol

Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial

Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease

Leukocytapheresis as promising therapy for inflammatory bowel disease

Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

Infliximab in refractory pouchitis complicated by fistulae following ileo‐anal pouch for ulcerative colitis

Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial

Recent advances in the management of Crohn's disease

Seasonal variations in onset of symptoms in Crohn's disease

Early or late guided missile in the treatment of Crohn's disease?

The association of MYO9B gene in Italian patients with inflammatory bowel diseases

The association of MY09B gene in Italian patients with inflammatory bowel diseases

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

Mesalazine vanishing time from rectal mucosa following its topical administration

Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients

Short‐chain fatty acid topical treatment in distal ulcerative colitis

Topical butyrate for acute radiation proctitis: randomised, crossover trial

An unusual complicated polypectomy and inverted colonic diverticula

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement

Suchergebnisse filtern